Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2005
08/04/2005US20050171018 Novel polypeptide and gene encoding the same
08/04/2005US20050171007 Therapeutic method
08/04/2005US20050170511 Oxa1p enhanced protein secretion
08/04/2005US20050170510 Using uniform electric charge to transfer vectors into cells; drug delivery; improving exogenous gene expression
08/04/2005US20050170506 Using nuclear transplantation as tool in generating pluripotent cells; tissue engineering; regenerative medicine
08/04/2005US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
08/04/2005US20050170503 In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
08/04/2005US20050170502 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage
08/04/2005US20050170501 Method for preparing tissue constructs
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170488 Multiply-substituted protease variants
08/04/2005US20050170462 Methods and host cells for improved cell culture
08/04/2005US20050170454 Cell culture medium
08/04/2005US20050170452 Method to engineer mammanlian-type carbohydrate structures
08/04/2005US20050170450 Expression vector for improving transcription of exogenous gene sequences in embryonic kidney cells
08/04/2005US20050170449 Soluble GlcNAc phosphotransferase
08/04/2005US20050170440 Treatment and diagnosis of insulin-resistant states
08/04/2005US20050170435 Heterotrimeric G protein/fluorescent protein fusion for monitoring and screening efficacy of drugs
08/04/2005US20050170408 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/04/2005US20050170407 Reagents and methods useful for detecting diseases of the lung
08/04/2005US20050170406 Using Burkitt's lymphoma-172 nucleotide sequences as diagnostic, prognostic and imaging tool in detection and treatment of infection and cell proliferative disorders of urogenital system
08/04/2005US20050170396 Using monoclonal antibodies to determine concentration of preferential membrane bound receptor in cancer cells; immunoassay
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050170006 preparing a completely autologous bioadhesive sealant composition; all the blood components come from the patient to whom the sealant will be used
08/04/2005US20050169979 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
08/04/2005US20050169962 Selective photopolymerization of biopolymers to create patterned structures and the patterning of cells within relatively homogenous slabs of biopolymer using dielectrophoresis; use as bioreactors, in bioassays, making artificial cartilage, or providing hepatic support
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169925 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent
08/04/2005US20050169923 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug
08/04/2005US20050169914 Novel functions for decay accelerating factor (DAF) in inflammation
08/04/2005US20050169902 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
08/04/2005US20050169898 Fusion of dendritic cells and antigen presenting cells; immunotherapy for stimulating an immune system; hybride cells; genetic engineering
08/04/2005US20050169897 Engraftable neural progenitor and stem cells for brain tumor therapy
08/04/2005US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase
08/04/2005US20050169888 Methods related to immunostimulatory nucleic acid-induced interferon
08/04/2005DE10100961B4 Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten Biocompatible material and coated with this material substrate for the growth of cells and artificial or constructed from cells grown organic implants
08/04/2005CA2555370A1 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005CA2554732A1 Methods of making and using skin-derived stem cells
08/04/2005CA2554330A1 Apparatus and methods for enzymatic debridement of skin lesions
08/04/2005CA2554192A1 Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell
08/04/2005CA2553883A1 Anti-cancer antibodies with reduced complement fixation
08/04/2005CA2553828A1 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing
08/04/2005CA2553756A1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications
08/04/2005CA2553745A1 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005CA2553199A1 System for up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the application of fields generated by specific electric and electromagnetic signals
08/04/2005CA2552892A1 O-linked glycosylation of peptides
08/04/2005CA2552891A1 Regulatory t cells suppress autoimmunity
08/04/2005CA2552756A1 Mouse model for psoriasis and psoriatic arthritis
08/03/2005EP1560026A1 Methods of detecting collagen degradation
08/03/2005EP1559785A1 Oligo- or polynucleotides for achieving RNA interference in mammalian cells
08/03/2005EP1559779A1 Modified inosine monophosphate dehydrogenases
08/03/2005EP1559778A1 Proliferation of hepatocyte precursors
08/03/2005EP1559777A1 Process for maturating small heptocyte-rich colonies into liver tissue
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1558928A1 Medium and method for measuring the efficacy of a tumour therapy
08/03/2005EP1558740A2 Recombinant protein variants
08/03/2005EP1558738A2 Methods for regulating plant gaba production
08/03/2005EP1558729A2 Rapidly degraded reporter fusion proteins
08/03/2005EP1558726A1 Vaccines against west nile virus
08/03/2005EP1558725A2 High expression locus vector based on ferritin heavy chain gene locus
08/03/2005EP1558724A2 Organellar targeting of rna and its use in the interruption of environmental gene flow
08/03/2005EP1558723A1 A means of producing and utilising a population of disease specific cytotoxic t-lymphoctyes
08/03/2005EP1558648A2 Human monoclonal antibodies against cd20
08/03/2005EP1558640A2 Trimeric binding proteins for trimeric cytokines
08/03/2005EP1558287A2 Uses of human zven antagonists
08/03/2005EP1558216A2 Cross-linked polymer matrices, and methods of making and using same
08/03/2005EP1558086A2 Cell targeting methods and compositions
08/03/2005EP1558085A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
08/03/2005EP1558076A2 Device and method for monitoring leukocyte migration
08/03/2005EP1379639B1 Mouse glucuronyl c5-epimerase, dna encoding the same and use thereof
08/03/2005EP1330517A4 Identification and characterization of an anthocyanin mutant (ant1) in tomato
08/03/2005EP1237900A4 Subunit optimized fusion proteins
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005EP1049777B1 Acpl dna and polypeptides
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0896620B1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/03/2005EP0885298B1 Plastid transformation in arabidopsis thaliana
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0702722B1 Plasmids suitable for gene therapy
08/03/2005CN1650021A Stable adenoviral vectors and methods for propagation thereof
08/03/2005CN1650019A Wound-inducible expression in plants
08/03/2005CN1650016A Method for modifying plant morphology, biochemistry and physiology including expression plant fission agent oxidase
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650003A A method for selecting cell lines to be used for nuclear transfer in mammalian species
08/03/2005CN1649999A Avian cell lines for the production of useful substances
08/03/2005CN1649998A Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
08/03/2005CN1649897A FALP proteins
08/03/2005CN1649890A Anti-protozoal vaccine
08/03/2005CN1649641A System and method for forming a non-ablative cardiac conduction block
08/03/2005CN1649618A Methods
08/03/2005CN1649483A ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants
08/03/2005CN1648251A Human oral scale-like cancer cis-platinum medicine resistant cell cDNA library and preparing method
08/03/2005CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression
08/03/2005CN1648246A Method for transferring Tibetan medicinal effective component into receptor cell using somatic cell cross breeding technology
08/03/2005CN1648241A Separating and purifying method for ox adrenal medella chromaffin cell
08/03/2005CN1648240A Periodic immersion air lifting type plant cell cultivating method and its cultivating device
08/03/2005CN1648150A Method for producing hydroxy alkanoic acid polymer
08/03/2005CN1213148C Biodegradable high oxidative stability oils
1 ... 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 ... 1827